These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27243141)

  • 1. Biomarkers for Cervical Cancer Prevention Programs: The Long and Winding Road From Discovery to Clinical Use.
    Wentzensen N; Silver MI
    J Low Genit Tract Dis; 2016 Jul; 20(3):191-4. PubMed ID: 27243141
    [No Abstract]   [Full Text] [Related]  

  • 2. ASCCP President 2019-2020 Vision.
    Stockdale CK
    J Low Genit Tract Dis; 2019 Jul; 23(3):187. PubMed ID: 31135653
    [No Abstract]   [Full Text] [Related]  

  • 3. Stage IV Cervical Cancer in a Patient Compliant With Current Management Guidelines for Abnormal Cytology: A Case Report.
    Mazul J; Perkins RB
    J Low Genit Tract Dis; 2017 Oct; 21(4):e40-e41. PubMed ID: 28953130
    [No Abstract]   [Full Text] [Related]  

  • 4. Executive summary--performance monitoring for cervical cancer screening programs in Canada.
    Screening Performance Indicators Working Group, Cervical Cancer Prevention and Control Network
    Chronic Dis Can; 2010 Dec; 31(1):45. PubMed ID: 21176414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting cervical cancer: organizations and researchers strive to improve screening, prevention.
    Printz C
    Cancer; 2014 Aug; 120(16):2381-2. PubMed ID: 25099731
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical cancer screening: the big step from morphology to molecular biology.
    Hillemanns P
    Arch Gynecol Obstet; 2013 Nov; 288(5):977. PubMed ID: 24096722
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical neoplasia guidelines: United States and europe compared.
    Stampler KM; Dunton CJ
    J Low Genit Tract Dis; 2010 Apr; 14(2):142-7. PubMed ID: 20354425
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical cancer screening by enhanced cytology: application of novel markers.
    Cheung AN; Guan XY; Ngan HY
    Hong Kong Med J; 2014 Dec; 20 Suppl 6():39-43. PubMed ID: 25482972
    [No Abstract]   [Full Text] [Related]  

  • 9. Saving the World's Women from Cervical Cancer.
    Tsu V; Jerónimo J
    N Engl J Med; 2016 Jun; 374(26):2509-11. PubMed ID: 27355529
    [No Abstract]   [Full Text] [Related]  

  • 10. Cervical cancer: what is the optimal age for routine testing?
    Rob L; Tachezy R; Robova H
    Future Oncol; 2015; 11(8):1137-40. PubMed ID: 25832869
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical setting.
    Purandare NC; Trevisan J; Patel II; Gajjar K; Mitchell AL; Theophilou G; Valasoulis G; Martin M; von Bünau G; Kyrgiou M; Paraskevaidis E; Martin-Hirsch PL; Prendiville WJ; Martin FL
    Bioanalysis; 2013 Nov; 5(21):2697-711. PubMed ID: 24180508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteomics and biomarkers for detection of cervical cancer].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient safety and the next generation of HPV DNA tests.
    Lee SH
    Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106
    [No Abstract]   [Full Text] [Related]  

  • 14. Public awareness and cervical cancer screening.
    Davies P
    Cytopathology; 2012 Jun; 23(3):143-5. PubMed ID: 22587553
    [No Abstract]   [Full Text] [Related]  

  • 15. Performance of an Human Papillomavirus Test in Samples From Women With Histopathologically Confirmed Invasive Cervical Cancer.
    Denny L; Mbatani N; Adams T; Van Wijk L; Behrens C; Tam T; Wright T; Stoler M
    J Low Genit Tract Dis; 2016 Jul; 20(3):e52-3. PubMed ID: 27224533
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.
    Luo H; Belinson JL; Du H; Liu Z; Zhang L; Wang C; Qu X; Pretorius RG; Wu R
    J Low Genit Tract Dis; 2017 Jan; 21(1):12-16. PubMed ID: 27851695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Human Papillomavirus Test Performance in Samples From Women With Histopathologically Confirmed Invasive Cervical Cancer.
    Austin RM; Olawaiye AB; Zhao C
    J Low Genit Tract Dis; 2016 Jul; 20(3):e52. PubMed ID: 27137506
    [No Abstract]   [Full Text] [Related]  

  • 18. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
    Poljak M
    Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
    [No Abstract]   [Full Text] [Related]  

  • 19. The Use of the Colposcopically Directed Punch Biopsy in Clinical Practice: A Survey of British Society of Colposcopy and Cervical Pathology (BSCCP)-Accredited Colposcopists.
    Myriokefalitaki E; Redman CW; Potdar N; Pearmain P; Moss EL
    J Low Genit Tract Dis; 2016 Jul; 20(3):234-8. PubMed ID: 27243143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative models of cervical cancer screening in Manitoba.
    DeRiviere L; Stopera S; Caeseele PV; Lotocki R
    Healthc Q; 2013; 16(1):77-85. PubMed ID: 24863312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.